Type your tag names separated by a space and hit enter

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy ID - 453324 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453324/all/Different_dosage_schedules_for_reducing_cardiotoxicity_in_cancer_patients_receiving_anthracycline_chemotherapy PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -